©2014 Baishideng Publishing Group Inc.
World J Clin Urol. Nov 24, 2014; 3(3): 351-357
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.351
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.351
Table 2 Clinicopathological parameters for patients with non-seminomatous testicular germ cell cancer n (%)
| Variables | Carcinoma (n = 14) | Control (n = 5) |
| Age in years mean (range) | 32.58 (16) | 30.75 (18) |
| Pathological stage | ||
| pT1 | 5 (26.3) | NA |
| pT2 | 5 (26.3) | NA |
| pT3 | 3 (15.8) | NA |
| pTx | 1 (18.2) | NA |
| Lymphnode metastasis | ||
| Nx | 7 (36.8) | NA |
| N0 | 4 (21.1) | NA |
| N3 | 3 (15.8) | NA |
| M-stage | ||
| Mx | 4 (21.1) | NA |
| M0 | 9 (47.7) | NA |
| M1 | 1 (5.3) | NA |
| Tumor markers | ||
| HCG increased | 13 (68.8) | NA |
| LDH increased | 7 (36.8) | NA |
| AFP increased | 12 (85.7) | NA |
| Clinical stage | ||
| IS | 8 (42.1) | NA |
| IIA | 2 (10.5) | NA |
| IIC | 3 (15.8) | NA |
| NA | 1 (5.3) | NA |
- Citation: Fischer N, Göke F, Kahl P, Splittstößer V, Lankat-Buttgereit B, Müller SC, Ellinger J. Programmed cell death protein 4 expression in renal cell carcinoma, penile carcinoma and testicular germ cell cancer. World J Clin Urol 2014; 3(3): 351-357
- URL: https://www.wjgnet.com/2219-2816/full/v3/i3/351.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v3.i3.351